Share Price and Basic Stock Data
Last Updated: November 18, 2025, 6:44 pm
| PEG Ratio | -13.49 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Advance Petrochemicals Ltd operates within the Chemicals – Inorganic – Others sector, with its stock currently priced at ₹200 and a market capitalization of ₹18.0 Cr. The company has shown notable revenue trends over the last few years, with reported sales of ₹37.09 Cr for the fiscal year ending March 2023, rising from ₹27.92 Cr in March 2022. However, sales for the fiscal year ending March 2024 declined slightly to ₹35.19 Cr. The trailing twelve months (TTM) revenue stands at ₹46.85 Cr, indicating a potential rebound in sales performance. Quarterly sales also reflect fluctuations, with a peak of ₹10.99 Cr in March 2024, while the most recent quarter, June 2025, reported sales of ₹9.51 Cr. The company’s ability to navigate these revenue dynamics highlights its resilience, although the periodic dips suggest challenges in maintaining consistent growth.
Profitability and Efficiency Metrics
Profitability metrics for Advance Petrochemicals show a mixed performance, with a reported net profit of ₹0.04 Cr and an operating profit margin (OPM) of 4.42%. The OPM has fluctuated significantly, recorded at a high of 11.31% in September 2022 but dropping to 1.88% in March 2023. The company’s return on equity (ROE) stands at 7.71%, while return on capital employed (ROCE) is at 9.56%. Efficiency ratios reflect a cash conversion cycle (CCC) of 37.41 days, suggesting reasonable operational efficiency. However, the company has faced challenges as evidenced by a decline in the net profit margin to 0.60% for March 2025, which is below the sector average. The interest coverage ratio (ICR) of 2.26x indicates that the company can comfortably meet its interest obligations, though it remains imperative to improve profitability for sustainable growth.
Balance Sheet Strength and Financial Ratios
The balance sheet of Advance Petrochemicals Ltd does not report any long-term borrowings or reserves, indicating a conservative capital structure. The company’s debt-to-equity ratio is at 2.69, suggesting a reliance on debt financing, which may pose risks in volatile market conditions. The price-to-book value (P/BV) ratio stands at 4.43x, indicating that the stock is trading at a premium relative to its book value, which is ₹44.86 per share. This premium suggests investor confidence but also raises concerns about overvaluation in light of the company’s profitability metrics. The current ratio is at 1.02, indicating adequate liquidity to meet short-term obligations. However, the quick ratio of 0.67 raises concerns about the company’s ability to cover liabilities without relying on inventory. Overall, while the balance sheet reflects some strengths, the high leverage and lack of reserves necessitate careful management of financial risks.
Shareholding Pattern and Investor Confidence
As of March 2025, the shareholding pattern of Advance Petrochemicals reveals that promoters hold 50.11% of the shares, while public shareholders account for 49.89%. This stability in promoter ownership suggests a strong commitment to the company’s long-term vision. The number of shareholders has gradually increased to 2,145, reflecting growing investor interest. However, the decline in promoter shareholding from 50.09% in March 2023 to 44.32% in June 2023 raises questions about potential dilution of control and investor confidence. The lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) indicates a limited institutional interest, which could impact the stock’s liquidity and overall market perception. The shift in public ownership dynamics emphasizes the need for the company to enhance its engagement with shareholders to build further confidence.
Outlook, Risks, and Final Insight
The outlook for Advance Petrochemicals Ltd hinges on its ability to stabilize and grow its revenue while improving profitability. The company faces risks related to high debt levels, as indicated by a total debt-to-equity ratio of 2.69, which could strain its financial health in adverse economic conditions. Additionally, fluctuating profitability metrics and declining margins highlight the challenges in sustaining operational efficiency. Strengths include a solid promoter holding and a reasonably efficient cash conversion cycle. To enhance its market position, the company should focus on optimizing its cost structure, reducing debt, and improving shareholder communication to attract institutional investors. A potential shift towards higher profitability could unlock greater investor value, while failure to address these risks may hinder its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Advance Petrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,924 Cr. | 45.2 | 125/45.2 | 146 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.9 Cr. | 31.8 | 48.3/25.8 | 69.1 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 208 Cr. | 266 | 410/238 | 12.4 | 211 | 3.01 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,952 Cr. | 564 | 730/408 | 33.9 | 157 | 0.53 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 346 Cr. | 443 | 536/376 | 16.9 | 144 | 0.68 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,033.38 Cr | 573.00 | 172.09 | 160.00 | 0.49% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.83 | 9.28 | 10.01 | 7.97 | 8.21 | 8.19 | 7.80 | 10.99 | 10.80 | 11.25 | 12.72 | 15.16 | 9.51 |
| Expenses | 8.94 | 8.23 | 9.34 | 7.82 | 8.13 | 7.40 | 7.45 | 10.38 | 10.41 | 11.15 | 12.35 | 14.51 | 9.09 |
| Operating Profit | 0.89 | 1.05 | 0.67 | 0.15 | 0.08 | 0.79 | 0.35 | 0.61 | 0.39 | 0.10 | 0.37 | 0.65 | 0.42 |
| OPM % | 9.05% | 11.31% | 6.69% | 1.88% | 0.97% | 9.65% | 4.49% | 5.55% | 3.61% | 0.89% | 2.91% | 4.29% | 4.42% |
| Other Income | 0.00 | 0.07 | 0.05 | -0.03 | 0.01 | 0.00 | 0.01 | 0.03 | 0.02 | 0.34 | 0.01 | 0.04 | 0.02 |
| Interest | 0.19 | 0.19 | 0.18 | 0.18 | 0.20 | 0.21 | 0.21 | 0.23 | 0.22 | 0.25 | 0.20 | 0.18 | 0.27 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.43 | 0.20 | 0.20 | 0.20 | 0.10 | 0.17 | 0.17 | 0.17 | 0.08 | 0.15 |
| Profit before tax | 0.58 | 0.81 | 0.42 | -0.49 | -0.31 | 0.38 | -0.05 | 0.31 | 0.02 | 0.02 | 0.01 | 0.43 | 0.02 |
| Tax % | 0.00% | 43.21% | 23.81% | -16.33% | 0.00% | 5.26% | 0.00% | 25.81% | 0.00% | 0.00% | 100.00% | 39.53% | 0.00% |
| Net Profit | 0.58 | 0.46 | 0.31 | -0.41 | -0.31 | 0.37 | -0.05 | 0.23 | 0.01 | 0.02 | 0.00 | 0.27 | 0.01 |
| EPS in Rs | 6.44 | 5.11 | 3.44 | -4.56 | -3.44 | 4.11 | -0.56 | 2.56 | 0.11 | 0.22 | 0.00 | 3.00 | 0.11 |
Last Updated: August 20, 2025, 12:25 am
Below is a detailed analysis of the quarterly data for Advance Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9.51 Cr.. The value appears to be declining and may need further review. It has decreased from 15.16 Cr. (Mar 2025) to 9.51 Cr., marking a decrease of 5.65 Cr..
- For Expenses, as of Jun 2025, the value is 9.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.51 Cr. (Mar 2025) to 9.09 Cr., marking a decrease of 5.42 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.42 Cr.. The value appears to be declining and may need further review. It has decreased from 0.65 Cr. (Mar 2025) to 0.42 Cr., marking a decrease of 0.23 Cr..
- For OPM %, as of Jun 2025, the value is 4.42%. The value appears strong and on an upward trend. It has increased from 4.29% (Mar 2025) to 4.42%, marking an increase of 0.13%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.02 Cr..
- For Interest, as of Jun 2025, the value is 0.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.18 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.07 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 39.53% (Mar 2025) to 0.00%, marking a decrease of 39.53%.
- For Net Profit, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.27 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.11. The value appears to be declining and may need further review. It has decreased from 3.00 (Mar 2025) to 0.11, marking a decrease of 2.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.54 | 11.20 | 10.46 | 8.85 | 12.74 | 21.29 | 13.90 | 17.44 | 27.92 | 37.09 | 35.19 | 49.94 | 46.85 |
| Expenses | 12.00 | 10.42 | 9.62 | 7.97 | 11.90 | 20.31 | 12.99 | 16.25 | 26.42 | 34.33 | 33.36 | 48.43 | 45.15 |
| Operating Profit | 0.54 | 0.78 | 0.84 | 0.88 | 0.84 | 0.98 | 0.91 | 1.19 | 1.50 | 2.76 | 1.83 | 1.51 | 1.70 |
| OPM % | 4.31% | 6.96% | 8.03% | 9.94% | 6.59% | 4.60% | 6.55% | 6.82% | 5.37% | 7.44% | 5.20% | 3.02% | 3.63% |
| Other Income | 0.18 | 0.01 | 0.03 | 0.03 | 0.08 | 0.09 | 0.10 | 0.12 | 0.06 | 0.09 | 0.06 | 0.41 | 0.09 |
| Interest | 0.40 | 0.45 | 0.53 | 0.58 | 0.64 | 0.77 | 0.77 | 0.72 | 0.72 | 0.74 | 0.88 | 0.85 | 1.02 |
| Depreciation | 0.13 | 0.20 | 0.19 | 0.18 | 0.18 | 0.19 | 0.17 | 0.22 | 0.40 | 0.79 | 0.70 | 0.60 | 0.55 |
| Profit before tax | 0.19 | 0.14 | 0.15 | 0.15 | 0.10 | 0.11 | 0.07 | 0.37 | 0.44 | 1.32 | 0.31 | 0.47 | 0.22 |
| Tax % | 36.84% | 64.29% | 53.33% | 46.67% | 10.00% | 0.00% | 0.00% | 27.03% | 31.82% | 28.03% | 32.26% | 36.17% | |
| Net Profit | 0.12 | 0.06 | 0.07 | 0.09 | 0.08 | 0.11 | 0.07 | 0.28 | 0.30 | 0.94 | 0.22 | 0.30 | 0.04 |
| EPS in Rs | 1.33 | 0.67 | 0.78 | 1.00 | 0.89 | 1.22 | 0.78 | 3.11 | 3.33 | 10.44 | 2.44 | 3.33 | 0.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 16.67% | 28.57% | -11.11% | 37.50% | -36.36% | 300.00% | 7.14% | 213.33% | -76.60% | 36.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 66.67% | 11.90% | -39.68% | 48.61% | -73.86% | 336.36% | -292.86% | 206.19% | -289.93% | 112.96% |
Advance Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 34% |
| 3 Years: | -4% |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 27% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:06 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61.71 | 73.98 | 80.26 | 51.97 | 53.00 | 41.83 | 32.30 | 53.16 | 63.93 | 35.92 | 93.56 | 70.97 |
| Inventory Days | 77.37 | 118.64 | 135.92 | 271.87 | 226.41 | 127.25 | 217.07 | 185.97 | 111.70 | 76.07 | 89.34 | 53.73 |
| Days Payable | 38.87 | 49.55 | 34.11 | 98.61 | 89.06 | 61.39 | 56.50 | 75.02 | 100.40 | 57.52 | 131.91 | 87.28 |
| Cash Conversion Cycle | 100.21 | 143.07 | 182.07 | 225.22 | 190.35 | 107.69 | 192.87 | 164.11 | 75.23 | 54.46 | 50.98 | 37.41 |
| Working Capital Days | 25.32 | 22.81 | 20.24 | 29.69 | 25.78 | 11.66 | 13.39 | 13.19 | 3.53 | -5.90 | 0.93 | -2.12 |
| ROCE % | 11.52% | 10.88% | 10.62% | 10.70% | 9.97% | 10.73% | 9.92% | 11.82% | 12.61% | 20.35% | 10.16% | 9.56% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Diluted EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Cash EPS (Rs.) | 10.00 | 10.12 | 19.28 | 7.75 | 5.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 44.86 | 40.43 | 38.03 | 27.54 | 24.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 44.86 | 41.50 | 39.10 | 28.61 | 25.32 |
| Revenue From Operations / Share (Rs.) | 554.84 | 390.97 | 412.12 | 310.20 | 193.80 |
| PBDIT / Share (Rs.) | 21.39 | 20.96 | 31.64 | 17.29 | 14.57 |
| PBIT / Share (Rs.) | 14.75 | 13.24 | 22.85 | 12.82 | 12.15 |
| PBT / Share (Rs.) | 5.28 | 3.48 | 14.62 | 4.84 | 4.17 |
| Net Profit / Share (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| PBDIT Margin (%) | 3.85 | 5.36 | 7.67 | 5.57 | 7.51 |
| PBIT Margin (%) | 2.65 | 3.38 | 5.54 | 4.13 | 6.26 |
| PBT Margin (%) | 0.95 | 0.88 | 3.54 | 1.56 | 2.15 |
| Net Profit Margin (%) | 0.60 | 0.61 | 2.54 | 1.05 | 1.59 |
| Return on Networth / Equity (%) | 7.48 | 5.93 | 27.59 | 11.92 | 12.76 |
| Return on Capital Employeed (%) | 15.20 | 16.84 | 35.07 | 24.49 | 21.89 |
| Return On Assets (%) | 1.19 | 0.95 | 6.00 | 1.91 | 2.17 |
| Long Term Debt / Equity (X) | 1.07 | 0.82 | 0.59 | 0.73 | 1.12 |
| Total Debt / Equity (X) | 2.69 | 2.47 | 2.10 | 2.75 | 3.36 |
| Asset Turnover Ratio (%) | 2.08 | 1.83 | 2.38 | 1.98 | 1.48 |
| Current Ratio (X) | 1.02 | 1.05 | 0.98 | 1.07 | 1.17 |
| Quick Ratio (X) | 0.67 | 0.65 | 0.45 | 0.52 | 0.40 |
| Inventory Turnover Ratio (X) | 6.56 | 4.65 | 4.37 | 3.22 | 2.10 |
| Interest Coverage Ratio (X) | 2.26 | 2.15 | 3.85 | 2.17 | 1.83 |
| Interest Coverage Ratio (Post Tax) (X) | 1.35 | 1.25 | 2.28 | 1.41 | 1.39 |
| Enterprise Value (Cr.) | 28.04 | 25.00 | 48.28 | 10.15 | 10.42 |
| EV / Net Operating Revenue (X) | 0.56 | 0.71 | 1.30 | 0.36 | 0.59 |
| EV / EBITDA (X) | 14.56 | 13.25 | 16.96 | 6.52 | 7.95 |
| MarketCap / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| Price / BV (X) | 4.43 | 4.58 | 12.15 | 1.52 | 1.59 |
| Price / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.07 | 0.08 |
After reviewing the key financial ratios for Advance Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has decreased from 10.12 (Mar 24) to 10.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 40.43 (Mar 24) to 44.86, marking an increase of 4.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 41.50 (Mar 24) to 44.86, marking an increase of 3.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.84. It has increased from 390.97 (Mar 24) to 554.84, marking an increase of 163.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.39. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 21.39, marking an increase of 0.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.75. This value is within the healthy range. It has increased from 13.24 (Mar 24) to 14.75, marking an increase of 1.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 5.28, marking an increase of 1.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For PBDIT Margin (%), as of Mar 25, the value is 3.85. This value is below the healthy minimum of 10. It has decreased from 5.36 (Mar 24) to 3.85, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has decreased from 3.38 (Mar 24) to 2.65, marking a decrease of 0.73.
- For PBT Margin (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 10. It has increased from 0.88 (Mar 24) to 0.95, marking an increase of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.48. This value is below the healthy minimum of 15. It has increased from 5.93 (Mar 24) to 7.48, marking an increase of 1.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.20. This value is within the healthy range. It has decreased from 16.84 (Mar 24) to 15.20, marking a decrease of 1.64.
- For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 1.19, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has increased from 0.82 (Mar 24) to 1.07, marking an increase of 0.25.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.69. This value exceeds the healthy maximum of 1. It has increased from 2.47 (Mar 24) to 2.69, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 1.5. It has decreased from 1.05 (Mar 24) to 1.02, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.67, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.56. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 6.56, marking an increase of 1.91.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.15 (Mar 24) to 2.26, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 1.25 (Mar 24) to 1.35, marking an increase of 0.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.04. It has increased from 25.00 (Mar 24) to 28.04, marking an increase of 3.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.56, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 14.56. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 14.56, marking an increase of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 4.43. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 24) to 4.43, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Advance Petrochemicals Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.2% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.48% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 449 (Industry average Stock P/E: 172.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.69
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | 36, Kothari Market, Kankaria Road, Ahmedabad Gujarat 380022 | info@advancepetro.com http://www.advancepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pulkit Goenka | Chairman & Managing Director |
| Ms. Aanchal Arvind Goenka | Non Executive Woman Director |
| Mr. Akshat Shukla | Non Exe. & Ind. Director |
| Mr. Arvind Vishwanath Goenka | Non Executive Director |
| Mrs. Palak Tapas Relia | Non Executive Woman Director |
| Mr. Harshil B Vadodariya | Non Exe. & Ind. Director |